SMTL ID : 4ge2.1 (1 other biounit)

Crystal structure of human protein tyrosine phosphatase PTPN9 (MEG2) complex with compound 3

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 75A: N-acetyl-4-[difluoro(phosphono)methyl]-L-phenylalanyl-N~5~-(3-iodobenzoyl)-L-ornithinamide(Non-covalent)

75A.1: 14 residues within 4Å: Chain A: R.36, Y.58, D.60, V.61, P.62, C.240, S.241, A.242, G.243, I.244, G.245, R.246, F.281, Q.284 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:Y.58, A:V.61, A:A.242, A:I.244, A:I.244, A:F.281, A:Q.284 Hydrogen bonds: A:D.60, A:D.60, A:D.60, A:A.242, A:G.243, A:I.244, A:G.245, A:R.246, A:Q.284 Water bridges: A:R.36, A:S.241, A:S.241

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, S. et al., A Highly Selective and Potent PTP-MEG2 Inhibitor with Therapeutic Potential for Type 2 Diabetes. J.Am.Chem.Soc. (2012)

Release Date

2012-10-31

Peptides

Tyrosine-protein phosphatase non-receptor type 9: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 9

Related Entries With Identical Sequence